[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337472-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337472-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","li-fraumeni-syndrome-predisposes-to-gastro-esophageal-junction-tumours","Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours","","Li-Fraumeni Syndrome (LFS), caused by germline TP53 pathogenic variants, predisposes individuals to multiple young-onset malignancies, notably sarcoma, breast and brain cancers, and an increased risk of gastric adenocarcinoma. A retrospective review of 65 LFS patients, including 53.8% who underwent endoscopy, found four (6.2%) gastro-esophageal junction adenocarcinomas, two detected on asymptomatic screening and early stage. No patients had a family history of gastrointestinal malignancy. Genomic analysis of TCGA data showed somatic TP53 variants in esophageal adenocarcinomas and differing frequencies in gastric cancers, supporting further investigation. Upper endoscopy surveillance is proposed, focusing on the GEJ.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/li-fraumeni-syndrome-predisposes-to-gastro-esophageal-junction-tumours/337472/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/li-fraumeni-syndrome-predisposes-to-gastro-esophageal-junction-tumours/337472.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What genetic cause defines Li-Fraumeni Syndrome in this study?","Question",{"text":63,"@type":64},"The study describes LFS as caused by germline pathogenic variants in TP53, the tumor suppressor gene.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How many gastro-esophageal junction adenocarcinomas were identified among the LFS cohort?",{"text":68,"@type":64},"Four patients (6.2%) with gastro-esophageal junction adenocarcinomas were identified, among 65 total LFS patients, with 53.8% having undergone endoscopy.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the study’s recommended surveillance approach for patients with LFS?",{"text":72,"@type":64},"The study proposes that upper endoscopy be recommended for all LFS patients, with a focus on appropriate surveillance of the gastro-esophageal junction (GEJ).","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337472,1790472185,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":97,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours  \nDouglas Tjandra1,2,3 · Alex Boussioutas1,2,3  \nReceived: 28 August 2023 / Accepted: 4 December 2023 / Published online: 11 January 2024 © Crown 2024  \nAbstract  \nLi-Fraumeni Syndrome (LFS), caused by germline pathogenic variants in TP53, predisposes to a wide range of young-onset malignancies, particularly sarcoma, breast and brain cancer. More recently, an increased risk of gastric adenocarcinoma has been recognised, although uptake of surveillance upper endoscopy is unclear. Our retrospective review of 65 patients with LFS, of whom 53.8% had undergone endoscopy, identified four patients (6.2%) with gastro-esophageal junction (GEJ) adenocarcinomas. Two cases were found on asymptomatic screening and were early stage. No cases had family history of gastrointestinal malignancy. Reviewing genomic data from The Cancer Genome Atlas Program, 76.4% of sporadic esophageal adenocarcinomas harboured somatic TP53 pathogenic variants, compared with 39.9% of non-cardia gastric cancers. This similar pattern observed in germline and sporadic cases warrants further investigation. We propose that upper endoscopy be recommended to all patients with LFS, with a focus on appropriate surveillance of the GEJ.  \nKeywords Li Fraumeni syndrome · TP53, hereditary gastric cancer syndromes · Endoscopic surveillance  \nIntroduction  \nLi-Fraumeni Syndrome (LFS) is defined by germline pathogenic variants in the tumour suppressor gene TP53 and is associated with increased rates of many different malignancies, some with up to 100% lifetime risk without appropriate intervention [1] . While the strongest associations have been demonstrated with sarcoma, breast cancer, brain tumoursand adrenocortical carcinomas, the increased risk of colorectal and, more recently, gastric adenocarcinomas have also been acknowledged [2] . The relative risk of esophageal cancer is less well characterised with conflicting reports [1, 3]. An analysis of the International Agency for Research on Cancer database identified 0.5% of individuals with esophageal cancer (15/3043) and 3.3%(101/3043) with gastric cancer [3, 4]. Gastro-esophageal junction (GEJ) tumours arise at  \n* Alex Boussioutas[alexb@alfred.org.au](alexb@alfred.org.au)  \n1 Familial Cancer Centre, The Peter MacCallum Cancer Centre, Melbourne, VIC, Australia  \n2 Department of Gastroenterology, Alfred Hospital, 99 Commercial Rd, Melbourne, VIC 3004, Australia  \n3 Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, VIC, Australia  \nthe histological transition between esophagus and stomach, and the commonly used Siewert classification divides GEJadenocarcinomas into three categories for which oncological management differs: Type 1 arising from distal esophagus (1 to 5 cm proximal to GEJ), Type 2 located at the true junction (between 1 cm proximal to 2 cm distal of the GEJ) and Type 3 located 2 to 5 cm distal to the GEJ [5] . In contrast, the American Joint Committee on Cancer stages all GEJ tumors with epicentre  ≤ 2 cm into the proximal stomach as esophageal cancers and those >2 cm as gastric cancers [5] . Consequently, GEJ tumors have been variably categorised in the literature as esophageal, gastric or a separate entity.  \nIn this context, expert consensus guidelines differ in their recommendations for upper endoscopy, or esophagogastroduodenoscopy, screening in LFS: North American guidelines support upper endoscopy every 2–5 years from the age of 25 alongside colonoscopy, while European guidelines do not routinely recommend upper endoscopy screening [2, 6] . The uptake of these recommendation is also unclear.  \nThere is a biological basis to suspect pathogenic variants in TP53 as a driver of upper gastrointestinal cancers. The Cancer Genome Atlas Program classified 559 sporadic esophageal and gastric cancers into distinct molecular phenotypes. When analysing adenocarcinoma, four subclasses were identified, but only one","cbCaifl1oxo5Hnc9","https://ap.wps.com/l/cbCaifl1oxo5Hnc9","pdf",1130523,"English","# Abstract\n# Introduction\n# Methods","[{\"question\":\"What genetic cause defines Li-Fraumeni Syndrome in this study?\",\"answer\":\"The study describes LFS as caused by germline pathogenic variants in TP53, the tumor suppressor gene.\"},{\"question\":\"How many gastro-esophageal junction adenocarcinomas were identified among the LFS cohort?\",\"answer\":\"Four patients (6.2%) with gastro-esophageal junction adenocarcinomas were identified, among 65 total LFS patients, with 53.8% having undergone endoscopy.\"},{\"question\":\"What is the study’s recommended surveillance approach for patients with LFS?\",\"answer\":\"The study proposes that upper endoscopy be recommended for all LFS patients, with a focus on appropriate surveillance of the gastro-esophageal junction (GEJ).\"}]","Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours | PDF",1790019264,13,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/efc3a6809175e1d91724f03c71077c06.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43d332a632a51ad99537a4c63ee76053.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f00333590c63d622f8a55ea64436951.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/192615588b3e61e68071b71fa4cbe841.webp",980,1301]